Pubblicazioni ufficiali Hikma Pharmaceuticals PLC

Azioni

Tempo reale stimato Cboe Europe Altri mercati azionari 11:28:18 04/07/2024			Variaz. 5gg	Var. 1 gen.
1.840 ^GBX	+0,93%		-1,92%	+2,79%

24/06	Teva lancia la versione generica del farmaco per il diabete Victoza di Novo Nordisk	RE
20/06	Fitch conferma il rating e l'outlook di Hikma Pharmaceuticals sulla base di una 'posizione di mercato difensiva'.	MT

Monthly statement on voting rights	30/06	CO
Changes in management and corporate officers	27/06	CO
Acquisition	17/06	CO
Shareholders meeting voting results	25/04	CO
Changes in management and corporate officers	15/04	CO
Annual ESG Report	22/03	CO
Mixed general shareholder meeting	22/03	CO
Annual Report	22/03	CO
Monthly statement on voting rights	29/02	CO
Slide show results	22/02	CO
Annual results	22/02	CO
Monthly statement on voting rights	31/01	CO
Monthly statement on voting rights	31/12	CO
Monthly statement on voting rights	30/11	CO
Monthly statement on voting rights	30/09/23	CO
Monthly statement on voting rights	31/08/23	CO
Changes in management and corporate officers	09/08/23	CO
Slide show half-year results	03/08/23	CO
1st-half-year results	03/08/23	CO
Threshold crossings	14/06/23	CO
Threshold crossings	23/05/23	CO
Monthly statement on voting rights	30/04/23	CO
Minutes of the general assembly	28/04/23	CO
Changes in management and corporate officers	12/04/23	CO
Monthly statement on voting rights	31/03/23	CO